InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Krempa David, Chief Business Officer. Officer active across 1 companies, notably Eton Pharmaceuticals, Inc.. In total, 4 filings have been published. The latest transaction was disclosed on 14 January 2026 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
US$26,0551,942 shares@ US$13.41630.0031% mcap22.3% of flow
Common Stock
SEC:0001437749-26-001288·
€26,0551,942 shares@ €13.41630.0031% mcap11.2% of flow
Common Stock
SEC:0001437749-26-001288:0·
US$90,7106,264 shares@ US$14.48110.011% mcap77.7% of flow
Common Stock
SEC:0001437749-25-037745·
€90,7106,264 shares@ €14.48110.011% mcap38.8% of flow
Common Stock
SEC:0001437749-25-037745:0·
4 of 4 declarations
About Krempa David
David Krempa is the Chief Business Officer at Eton Pharmaceuticals, Inc. He oversees the business and development strategies of the company. His role is essential in ensuring Eton's growth and expansion.
